Skip to content

Comparison of Medical and Surgical Treatment of Uncomplicated Acute Appendicitis in Children

Comparison of Medical and Surgical Treatment of Uncomplicated Acute Appendicitis in Children

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02991937
Enrollment
39
Registered
2016-12-14
Start date
2016-12-31
Completion date
2020-12-01
Last updated
2022-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Appendicitis

Brief summary

Several prior studies have demonstrated that medical management of acute appendicitis in adults is a safe first-line therapy option. This study aims to determine whether non-operative management of uncomplicated acute appendicitis with antibiotics is non-inferior to operative management in a pediatric population. This study will be a randomized controlled trial comparing non-operative management with antibiotics to surgical management of uncomplicated acute appendicitis. The hypothesis is that antibiotics are not worse than surgery for the treatment of uncomplicated appendicitis in children.

Interventions

DRUGPiperacillin/Tazobactam

24 hours of IV antibiotic administration

PROCEDURESurgical Treatment

Appendectomy

Sponsors

NYU Langone Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Years to 17 Years
Healthy volunteers
Yes

Inclusion criteria

* first episode of appendicitis * Pain \< 48 hours * White blood cell count \< 18,000 * temperature \< 103º F * radiographic evidence of acute appendicitis on ultrasound or CT without evidence of perforation * appendiceal diameter \< 11 mm * ability to take oral antibiotics

Exclusion criteria

* Prior antibiotic treatment for appendicitis * presence of medical condition prohibiting surgical therapy * radiographic or clinical evidence of abscess or perforation * appendiceal mass, positive pregnancy test * other diagnosis equally as likely as appendicitis * pain for ≥ 48 hours, white blood cell count ≥ 18,000, temperature ≥ 103º F, or appendiceal diameter ≥ 11 mm * inability to take oral antibiotics.

Design outcomes

Primary

MeasureTime frameDescription
Pediatric Quality of Life Inventory (PedsQL) Generic Core Scale - Parent1 YearBrief, standardized, generic assessment instrument that systematically assesses patients' and parents' perceptions of health-related quality of life (HRQOL) in pediatric patients with chronic health conditions using pediatric cancer as an exemplary model. PedsQL consists of 23 items scored on a 5-point Likert scale (0=never to 4=almost always). Items are reversed scored and linearly transformed to a 0-100 scale (0=100, 1=75, 2=50, 3=25, and 4=0). The total score range is 0-100; the higher the score, the better the HRQOL.

Secondary

MeasureTime frameDescription
Readmission Rates1 YearPercentage of patients readmitted to the hospital after discharge.
Incidence of Long-term Complications in Medical Therapy Group1 YearIncidence of long-term complications will be reported as number of cases where appendicitis reoccurred resulting in appendectomies in participants of the medical therapy arm. This data will be obtained from medical record review.

Countries

United States

Participant flow

Participants by arm

ArmCount
Medical Therapy
Subjects in the medical therapy arm will be treated with piperacillin/tazobactam for at least 24 hours. Ciprofloxacin/metronidazole will be used in penicillin-allergic patients. Subjects will be maintained on nothing by mouth with intravenous fluids for at least 12 hours. Subjects will be transitioned to oral antibiotics when their WBC is normal, they have a decrease in CRP by ≥ 15%, and they have been afebrile for 24 hours on IV antibiotics. Piperacillin/Tazobactam: 24 hours of IV antibiotic administration
20
Surgical Intervention
Subjects in the surgical treatment arm will receive intravenous antibiotics until the time of operation, and will be maintained on intravenous fluids and no oral intake until they undergo appendectomy as per standard of care. Appendectomy will occur within 24 hours of enrollment. Subjects in the surgical treatment arm will receive post-operative antibiotics as per standard of care. Piperacillin/Tazobactam: 24 hours of IV antibiotic administration Surgical Treatment: Appendectomy
19
Total39

Baseline characteristics

CharacteristicMedical TherapySurgical InterventionTotal
Age, Continuous10.2 years9.7 years10 years
Ethnicity (NIH/OMB)
Hispanic or Latino
6 Participants6 Participants12 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
14 Participants13 Participants27 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants1 Participants1 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
2 Participants1 Participants3 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
7 Participants8 Participants15 Participants
Race (NIH/OMB)
White
11 Participants9 Participants20 Participants
Region of Enrollment
United States
20 participants19 participants39 participants
Sex: Female, Male
Female
7 Participants6 Participants13 Participants
Sex: Female, Male
Male
13 Participants13 Participants26 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 200 / 19
other
Total, other adverse events
8 / 200 / 19
serious
Total, serious adverse events
0 / 200 / 19

Outcome results

Primary

Pediatric Quality of Life Inventory (PedsQL) Generic Core Scale - Parent

Brief, standardized, generic assessment instrument that systematically assesses patients' and parents' perceptions of health-related quality of life (HRQOL) in pediatric patients with chronic health conditions using pediatric cancer as an exemplary model. PedsQL consists of 23 items scored on a 5-point Likert scale (0=never to 4=almost always). Items are reversed scored and linearly transformed to a 0-100 scale (0=100, 1=75, 2=50, 3=25, and 4=0). The total score range is 0-100; the higher the score, the better the HRQOL.

Time frame: 1 Year

ArmMeasureValue (MEDIAN)
Medical TherapyPediatric Quality of Life Inventory (PedsQL) Generic Core Scale - Parent91.3 score on a scale
Surgical InterventionPediatric Quality of Life Inventory (PedsQL) Generic Core Scale - Parent90.2 score on a scale
Secondary

Incidence of Long-term Complications in Medical Therapy Group

Incidence of long-term complications will be reported as number of cases where appendicitis reoccurred resulting in appendectomies in participants of the medical therapy arm. This data will be obtained from medical record review.

Time frame: 1 Year

ArmMeasureValue (NUMBER)
Medical TherapyIncidence of Long-term Complications in Medical Therapy Group30 Number of cases in 20 participants
Secondary

Readmission Rates

Percentage of patients readmitted to the hospital after discharge.

Time frame: 1 Year

ArmMeasureValue (NUMBER)
Medical TherapyReadmission Rates25 percentage of participants
Surgical InterventionReadmission Rates0 percentage of participants

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026